# tDCS as an add-on Treatment in SSRI-resistant OCD

> **NCT02407288** · NA · UNKNOWN · sponsor: **Hôpital le Vinatier** · enrollment: 46 (estimated)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DEVICE:** transcranial dirrect current stimulation
- **DEVICE:** Sham tDCS

## Key facts

- **NCT ID:** NCT02407288
- **Lead sponsor:** Hôpital le Vinatier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03-12
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407288, "tDCS as an add-on Treatment in SSRI-resistant OCD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02407288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*